AAAAAA

   
Results: 1-23 |
Results: 23

Authors: CESANO A VISONNEAU S WOLFE JH JEGLUM KA FERNANDEZ J GILLIO A OREILLY RJ SANTOLI D
Citation: A. Cesano et al., TOXICOLOGICAL AND IMMUNOLOGICAL EVALUATION OF THE MHC-NON-RESTRICTED CYTOTOXIC T-CELL LINE TALL-104, Cancer immunology and immunotherapy, 44(3), 1997, pp. 125-136

Authors: SARAFOGLOU K BOULAD F GILLIO A SKLAR C
Citation: K. Sarafoglou et al., GONADAL-FUNCTION AFTER BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIADURING CHILDHOOD, The Journal of pediatrics, 130(2), 1997, pp. 210-216

Authors: AVIGAN D PAPADOPOULOS E BOULAD F CASTROMALASPINA H CHILDS B MCKINNON S GILLIO A KERNAN N SZABOLCS P YOUNG J OREILLY R SMALL TN
Citation: D. Avigan et al., OPPORTUNISTIC INFECTIONS FOLLOWING RELATED AND UNRELATED T-CELL DEPLETED BONE-MARROW TRANSPLANTATION, Experimental hematology, 24(9), 1996, pp. 669-669

Authors: GEORGE D GILLIO A VANSYCKLE K KEMAN N SMALL T SZABOLCS P MALASPINA HC WILLIAMS T OREILLY R BOULAD F
Citation: D. George et al., PLATELET SENSITIVITY TO TAPERING DOSES OF CYCLOSPORINE-A (CSA) IN CHILDREN WITH SEVERE APLASTIC-ANEMIA (SAA), Blood, 88(10), 1996, pp. 2770-2770

Authors: GARDNER S BOULAD F GILLIO A KERNAN N OREILLY R SMALL T SZABOLCS P TAN C GANSHAW L VANSYCKLE K MOSKOWITZ C YAHALOM J
Citation: S. Gardner et al., HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM-CELL RESCUE IN PEDIATRIC-PATIENTS WITH REFRACTORY HODGKINS-DISEASE, Blood, 88(10), 1996, pp. 481-481

Authors: KERNAN NA BOULAD F GILLIO A SMALL T VANSYCKLE K SZABOLCS P COLLINS NH YANG SY LANDREY C MITCHELLGRANT J BLEAU S DUPONT B OREILLY RJ
Citation: Na. Kernan et al., REDUCED ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) DO NOT COMPROMISE LEUKEMIA FREE SURVIVAL FOLLOWING T-CELL DEPLETED (SBA-E) UNRELATED MARROW TRANSPLANTS FOR PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 1059-1059

Authors: BOULAD F CASTROMALASPINA H PAPADOPOULOS E CHILDS B GILLIO A KERNAN N SMALL T SZABOLCS P TAYLOR J VANSYCKLE K WILLIAMS T YOUNG J OREILLY R
Citation: F. Boulad et al., MONOSOMY-7 PREDICTS A POOR OUTCOME AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 88(10), 1996, pp. 2457-2457

Authors: BOULAD F GILLIO A GARDNER S KERNAN N SMALL T VANSYCKLE K WILLIAMS T YAHALOM J OREILLY R
Citation: F. Boulad et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT) OR AUTOLOGOUS BMT (ABMT) FOR THE TREATMENT OF PEDIATRIC-PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL), Blood, 88(10), 1996, pp. 2458-2458

Authors: BOULAD F BROMLEY M BLACK P HELLER G SARAFOGLOU K GILLIO A PAPADOPOULOS E SKLAR C
Citation: F. Boulad et al., THYROID-DYSFUNCTION FOLLOWING BONE-MARROW TRANSPLANTATION USING HYPERFRACTIONATED RADIATION, Bone marrow transplantation, 15(1), 1995, pp. 71-76

Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH BOULAD F CASTROMALASPINA H CHILDS B GILLIO A KERNAN NA SMALL T YOUNG J OREILLY RJ
Citation: S. Mackinnon et al., DONOR LEUKOCYTE INFUSIONS FOR MOLECULAR OR CYTOGENETIC RELAPSE OF CMLFOLLOWING ALLOGENEIC BMT - GRAFT-VERSUS-LEUKEMIA RESPONSES WITH MINIMAL TOXICITY, Blood, 86(10), 1995, pp. 2251-2251

Authors: KERNAN NA YOUNG J PAPADOPOULOS E BLACK P SMALL TN MACKINNON S CASTROMALASPINA H CHILDS B GILLIO A BOULAD F HELLER G OREILLY RJ
Citation: Na. Kernan et al., ANTITHYMOCYTE GLOBULIN (ATGAM) AND METHYLPREDNISOLONE (MP) PROMOTE ENGRAFTMENT OF T-CELL DEPLETED (SBA-E-) BMTS FROM HLA-IDENTICAL SIBLINGS, Blood, 86(10), 1995, pp. 2470-2470

Authors: CASTROMALASPINA H CHILDS B LAVER J SHANK B BROCHSTEIN J GILLIO A FLOMENBERG N YOUNG J BOULAD F BLACK P KERNAN N FUKS Z OREILLY R
Citation: H. Castromalaspina et al., HYPERFRACTIONATED TOTAL LYMPHOID IRRADIATION AND CYCLOPHOSPHAMIDE FORPREPARATION OF PREVIOUSLY TRANSFUSED PATIENTS UNDERGOING HLA-IDENTICAL MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA, International journal of radiation oncology, biology, physics, 29(4), 1994, pp. 847-854

Authors: CASTROMALASPINA H CHILDS B GILLIO A PAPADOPOULOS E BOULAD F YOUNG J SMALL T MACKINNON S KERNAN N COLLINS N REYES B HELLER G OREILLY R
Citation: H. Castromalaspina et al., BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES AND SECONDARY ACUTE MYELOCYTIC-LEUKEMIA, Experimental hematology, 22(8), 1994, pp. 688-688

Authors: GASPARETTO C SMITH C GILLIO A STOPPA AM MOORE MAS OREILLY RJ
Citation: C. Gasparetto et al., ENRICHMENT OF PERIPHERAL-BLOOD STEM-CELLS IN A PRIMATE MODEL-FOLLOWING ADMINISTRATION OF A SINGLE-DOSE OF RH-IL-1-BETA, Bone marrow transplantation, 14(5), 1994, pp. 717-723

Authors: BOULAD F GILLIO A SMALL TN BONILLA MA PHILIPS P RUGGIERO M EMANUEL D GHAVIMI F KERNAN NA
Citation: F. Boulad et al., CORRECTION OF NEUTROPENIA WITH RHUG-CSF AFTER LOSS OF RESPONSE TO RHUGM-CSF FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANT, Bone marrow transplantation, 13(5), 1994, pp. 661-663

Authors: BONILLA MA DALE D ZEIDLER C LAST L REITER A RUGGEIRO M DAVIS M KOCI B HAMMOND W GILLIO A WELTE K
Citation: Ma. Bonilla et al., LONG-TERM SAFETY OF TREATMENT WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (R-METHUG-CSF) IN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIAS, British Journal of Haematology, 88(4), 1994, pp. 723-730

Authors: BOULAD F GILLIO A SMALL T BLACK P KERNAN N OREILLY RJ
Citation: F. Boulad et al., BONE-MARROW TRANSPLANTATION (BMT) FOR THE TREATMENT OF CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA (AML) - THE MSKCC EXPERIENCE, Blood, 84(10), 1994, pp. 10000205-10000205

Authors: MICHEL G BOULAD F SMALL T BLACK P HELLER G CHILDS B CASTROMALASPINA H GILLIO A MACKINNON S PAPADOPOULOS E YOUNG J KERNAN NA OREILLY RJ
Citation: G. Michel et al., RISK OF RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) WITH PRIOR SKIN INVOLVEMENT, Blood, 84(10), 1994, pp. 10000207-10000207

Authors: BOULAD F STEINHERZ P REYES B GILLIO A SMALL T KERNAN NA OREILLY RJ
Citation: F. Boulad et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) VERSUS CHEMOTHERAPY FOR THE TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN 2ND REMISSION (CR-2) - THE MSKCC EXPERIENCE, Blood, 84(10), 1994, pp. 10000251-10000251

Authors: CASTROMALASPINA H CHILDS B GILLIO A PAPADOPOULOS E BOULAD F YOUNG J SMALL T MACKINNON S KERNAN N COLLINS N REYES B OREILLY RJ
Citation: H. Castromalaspina et al., IMPROVED DISEASE-FREE SURVIVAL IN PATIENTS WITH LOW-RISK (LESS-THAN-5-PERCENT MARROW BLASTS) MYELODYSPLASTIC SYNDROMES TREATED WITH HLA-IDENTICAL SIBLING-DERIVED T-CELL DEPLETED (SBA-E-) MARROW TRANSPLANTS, Blood, 84(10), 1994, pp. 10000518-10000518

Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH BOULAD F CASTROMALASPINA H CHILDS B GILLIO A KERNAN NA SMALL T YOUNG J OREILLY RJ
Citation: S. Mackinnon et al., ADOPTIVE IMMUNOTHERAPY USING ESCALATING DOSES OF DONOR LEUKOCYTES FORRELAPSED CHRONIC MYELOID-LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000538-10000538

Authors: KERNAN NA SCHROEDER M PRETI RA BOULAD F SMALL TN EMANUEL D GILLIO A CIAVARELLA D ADAMSON J RUBINSTEIN P OREILLY RJ
Citation: Na. Kernan et al., HEMATOPOIETIC AND IMMUNE RECONSTITUTION WITH UMBILICAL-CORD INFUSION IN A PATIENT WITH WISKOTT-ALDRICH SYNDROME (WAS), Blood, 82(10), 1993, pp. 10000171-10000171

Authors: GILLIO A BOULAD F SMALL T KERNAN N REYES B CHILDS B CASTROMALASPINA H OREILLY RJ
Citation: A. Gillio et al., TREATMENT OF SEVERE APLASTIC-ANEMIA (SAA) IN CHILDREN - THE MSKCC EXPERIENCE, Blood, 82(10), 1993, pp. 10000177-10000177
Risultati: 1-23 |